Nasdaq Lptx News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Leap Therapeutics (NASDAQ:LPTX – Get Free Report) and Dyne Therapeutics (NASDAQ:DYN – Get Free Report) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, valuation, analyst recommendations, institutional ownership, risk, profitability and earnings. Volatility and Risk Leap Therapeutics has a beta […]

HC Wainwright reaffirmed their buy rating on shares of Leap Therapeutics (NASDAQ:LPTX – Free Report) in a research report report published on Tuesday, Benzinga reports. HC Wainwright currently has a $7.00 price target on the stock. HC Wainwright also issued estimates for Leap Therapeutics’ Q1 2024 earnings at ($0.58) EPS, Q2 2024 earnings at ($0.59) […]

Leap Therapeutics (NASDAQ:LPTX – Get Free Report) issued its quarterly earnings results on Monday. The company reported ($0.51) EPS for the quarter, topping analysts’ consensus estimates of ($0.58) by $0.07, MarketWatch Earnings reports. Leap Therapeutics Stock Performance LPTX stock opened at $1.56 on Wednesday. Leap Therapeutics has a 1-year low of $1.24 and a 1-year […]

Leap Therapeutics, Inc. (NASDAQ:LPTX – Get Free Report) saw a significant increase in short interest during the month of October. As of October 31st, there was short interest totalling 744,200 shares, an increase of 24.6% from the October 15th total of 597,500 shares. Approximately 3.2% of the shares of the company are sold short. Based […]

Leap Therapeutics (NASDAQ:LPTX – Get Free Report) and Monopar Therapeutics (NASDAQ:MNPR – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, valuation, risk, earnings, analyst recommendations, dividends and institutional ownership. Risk & Volatility Leap Therapeutics has a […]